[New option in the management of cancer pain in Hungary: short acting oral opioid therapy]

Orv Hetil. 2015 Jun 21;156(25):1003-6. doi: 10.1556/650.2015.30171.
[Article in Hungarian]

Abstract

Short acting oral morphine has recently been registered again in Hungary. Short acting oral morphine has two essential indications: dose titration at initiation of major analgesic therapy and treatment of breakthrough pain appearing beside round the clock major analgesic therapy. The clinical management of short acting oral morphine is summarised in this article.

Keywords: breakthrough pain; cancer pain; daganatos fájdalom; dose titration; morfin; morphine; titrálás; áttöréses fájdalom.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Administration, Oral
  • Analgesics, Opioid / administration & dosage*
  • Analgesics, Opioid / adverse effects
  • Analgesics, Opioid / pharmacokinetics*
  • Analgesics, Short-Acting / administration & dosage*
  • Analgesics, Short-Acting / pharmacokinetics*
  • Drug Administration Schedule
  • Drug Approval
  • Fentanyl / administration & dosage
  • Fentanyl / pharmacokinetics
  • Humans
  • Hungary
  • Hydromorphone / administration & dosage
  • Hydromorphone / pharmacokinetics
  • Morphine / administration & dosage
  • Morphine / pharmacokinetics
  • Neoplasms / complications*
  • Oxycodone / administration & dosage
  • Oxycodone / pharmacokinetics
  • Pain / drug therapy*
  • Pain / etiology*
  • Pain Measurement
  • Therapeutic Equivalency
  • Time Factors

Substances

  • Analgesics, Opioid
  • Analgesics, Short-Acting
  • Morphine
  • Oxycodone
  • Hydromorphone
  • Fentanyl